Working… Menu

Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00336453
Recruitment Status : Completed
First Posted : June 13, 2006
Last Update Posted : December 17, 2009
Information provided by:
Protein Sciences Corporation